NCT03101358 - Study of Topical SOR007 Ointment for Cutaneous Metastases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

April 29, 2020

Study Completion Date

April 29, 2020

Conditions

Cutaneous Metastasis

Interventions

DRUG

SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment

One (1) Finger Tip Unit (FTU), or approximately 0.5 g, of SOR007 ointment will be applied topically to a 50 cm2 treatment area.

Trial Locations (4)

Memorial Sloan Kettering Cancer Center, New York

Houston Methodist, Houston

University of Southern California, Los Angeles

Sarcoma Oncology Center, Santa Monica